SCHEMBL24335187

SCHEMBL24335187

CCOc1cc(OC)cc(-c2cc3cnc(Cl)nc3cc2OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ FGFR1 P11362 14/20 0.47
▸ FGFR2 P21802 5/20 0.39
▸ FGFR4 P22455 5/20 0.39
▸ FGFR3 P22607 5/20 0.39
▸ KDR P35968 4/20 0.39
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ ENPP1 P22413 1/20 0.35
▸ TUBB4A P04350 1/20 0.35
▸ TUBB P07437 1/20 0.35
▸ TUBA3C P0DPH7 1/20 0.35
▸ TUBA1B P68363 1/20 0.35
▸ TUBA4A P68366 1/20 0.35
▸ TUBB4B P68371 1/20 0.35
▸ TUBB3 Q13509 1/20 0.35
▸ TUBB2A Q13885 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29385053 0.92 KDM4E (0.65) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL15413235 0.92 KDM4E (0.65) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
Hydrochloric Acid SCHEMBL28010166 0.91 KDM4E (0.63) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL24336038 0.87 FGFR1 (0.46) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL29385006 0.80 FGFR1 (0.55) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL16667808 0.80 FGFR1 (0.55) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL18612966 0.80 CYP11B1 (0.49) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL20331733 0.80 NPC1 (0.51) KDM4EALDH1A1SMN1; SMN2FGFR1CYP11B1
SCHEMBL16668439 0.78 FGFR1 (0.52) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2
SCHEMBL31647846 0.78 FGFR1 (0.59) KDM4EALDH1A1SMN1; SMN2FGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3395814-B1 INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR BLUEPRINT MEDICINES CORP (US) 2022-04-06 — — EP disclosed
Send feedback